Hikal Ltd, a leading Pharmaceuticals company based in India, specializes in manufacturing chemical intermediates, specialty chemicals, and active pharma ingredients. With a risk rating score of 35.5, Hikal Ltd is considered a high-risk company. Its ESG score reflects its commitment to sustainability and governance practices. The company's innovative products cater to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Hikal Ltd's revenue primarily comes from its pharmaceutical segment, showcasing its strong presence in the industry.